The UK’s life sciences sector is world-class - and Northern Ireland is a vital part of that story. BIA CEO and Chair are pleased to be in Belfast yesterday celebrating NI’s contribution to our national pipeline. Huge thanks to the HIRANI team for the warm welcome.

Our April roundup of Lab bench to front bench is out! ➡️ shorturl.at/VAyga In this edition we cover our influence activity in April, including: 🔸 How BIA is strengthening UK medicine manufacturing 🔸 What we've been reading and listening to 🔸 What's coming up across BIA Policy and Public Affairs

$2.1 billion. That is the scale of the Series B funding secured by Isomorphic Labs, a landmark moment for #UKBiotech 🔗➡️ shorturl.at/9cgDx The funding will accelerate AI Drug Design Engine, and bringing AI, engineering and clinical talent together to tackle biological and medical challenges.

Today, we publish BIA's health data vision 2035: harnessing a national asset for growth. ➡️ shorturl.at/G00kY The report sets out how the UK can securely use its health data as a strategic national asset to drive economic growth, improve patient outcomes, and support long-term NHS sustainability.

While financing in Q1 2026 sits below last year's peak, Q1 2025 was influenced by a small number of megadeals. A look beneath the data reveals an uptick in activity. ➡️ biotechfinance.org Deal volume is up 67%. Twenty-five transactions were completed this quarter, compared to just 15 in Q1 2025.

Global uncertainty and technological convergence are reshaping the sector, and the pressure on leaders to adapt has never been greater. 🔗➡️ shorturl.at/p44l2 Join us at #WomeninBiotech at Alderley Park for an evening exploring how leaders are managing organisational change.

We are excited to announce the official launch of our report on Unlocking investment in #UKbiosolutions ➡️ lnkd.in/ewnJKAjD The £1.46 billion raised by the UK biosolutions sector since 2018 signals a strong and steadily growing industry. Read the full report in the link above

The UK #LifeSciences sector continues to grow, bringing with it exciting new job opportunities that are driving innovation and improving patient outcomes. Visit our website to explore sector jobs ➡️ shorturl.at/FpLqb

If you enjoyed our #WomeninBiotech tours, we’re excited to announce that Women in Biotech is coming to Alderley Park! 🔗 ➡️ shorturl.at/TXh0t Join us for an engaging event exploring representation and diversity across the sector. This event is open to all, don’t miss out! 🎟️ Book your ticket above ⤴️

Our latest edition of Lab bench to front bench is out now! ➡️ shorturl.at/GfN06 In this edition, we take a look back at February and the ways we've kept life sciences and our members at the top of the political agenda. #LabBenchToFrontBench #UKLifeSciences

Three challenges across the year to raise vital funds for individuals living with #MuscularDystrophy ➡️ shorturl.at/QmrcQ 🚴 Pedal Paddle Peak 🏃 Bidwells Oxford 10K 🏃 Bidwells Cambridge 10K Help drive progress in research and shine a spotlight on 110,000 people living with muscle-wasting conditions.

In the run-up to Rare Diseases Day on Saturday, Emily Klein, has written a blog reflecting on the importance of #RareDiseaseDay in bringing visibility to those affected by a rare condition and serving as a focal point for advocacy in this space. 🧬🧑‍⚕️ Read the blog ➡️ lnkd.in/eq6ymypd

Katherine Powers and Max Stanyard (RSM) examine how regulatory reform, data-driven partnerships, and smarter cross-border operating models are creating new pathways for growth across both markets. Read the full blog ➡️ www.bioindustry.org/resource/res... #LifeSciences

Influencing policy and government is a major part of BIA's work. That's why our Policy is excited to announce our new monthly blog series, #LabBenchtoFrontBench. Each edition will showcase our influencing activity across the month. Read our first edition ➡️ shorturl.at/VMPpF #UKLifeSciences

We welcome the fantastic news from FUJIFILM Biotechnologies on the opening of state-of-the-art #Biomanufacturing and process development facilities in the UK. This investment is a strong vote of confidence in the UK as a place to build, scale & deliver globally competitive #LifeSciences capability.

#Biosolutions are reshaping food, agriculture, materials and #Biofuels, powering both economic growth and the transition to #NetZero. These innovations are essential for transitioning from fossil fuel dependency to a sustainable bioeconomy. Register your attendance today ➡️ shorturl.at/myR4I

The latest UK biotech financing insights are now live! Our findings show that 2025 was a year of strategic resilience as the UK stood its ground in a tough global market. ➡️ biotechfinance.org Our message to the government and #Investors is clear: it’s time to deliver and deploy. #InvestinBiotech

We kicked off Cohort 4 for the #WomeninBiotech Mentoring Program, and what an energising start it was! We brought together an exceptional group of mentors and mentees from across the biotech ecosystem to support each other in their career aspirations and personal development.

BIA’s new policy report, ‘Innovation to impact: unlocking patient access to rare disease medicines’, is out. ➡️ lnkd.in/eYUbx9jR Developed by BIA's RDIG, the report builds on the MHRA's plans to develop a new regulatory pathway for #RareDiseaseTherapies. Explore full insights in the link above.

Yesterday, the Science, Innovation and Technology Committee questioned Steve as Chair of the Office for Life Sciences, Samantha Roberts, Lord Vallance, and Dr Zubir Ahmed MP, to scrutinise what the government is doing to boost the UK’s global competitiveness in #LifeSciences.

Take a look at our newly released UK biotech financing Q3 report➡️ biotechfinance.org Now is the time to double down on #Investment & the #IndustrialStrategy, not pursue short-term cost savings. The long-term economic & social returns from supporting life science outweigh immediate fiscal pressures.

Secure your Early Bird tickets for the 22nd Annual #BioProcessUK Conference before they expire! ➡️ shorturl.at/IZPif Don’t miss this opportunity to forge valuable business connections, stay updated on the latest #bioprocessing innovations, and gain insights from industry-leading speakers.

In the latest edition of #PULSE: Empowering the future of UK #biotech, we take a closer look at MarraBio ➡️ shorturl.at/dPxIG MarraBio is an innovative company focused on developing cutting-edge solutions at the intersection of #Biology and #Technology. Read the case study in the link above

"London Life Sciences Week (LLSW) is going to collect the best companies, investors and academics in the UK here to London. But more than that, it’s now attracting people from overseas." Ros Deegan, CEO of @omasstx.bsky.social 🧪 Visit: lifesciencesweek.london

Are you excited for the RNA Vaccines and Therapeutics Conference? 👉 shorturl.at/56E8C Hosted by @CPI, @imperialcollegeldn.bsky.social, and BIA, this two-day event will spotlight the latest breakthroughs in encoded #RNAmedicines. 📅 23–24 September 2025 📍 London, The Royal College of Physicians

This September marks #BloodCancerAwarenessMonth, and we’re proud to support Blood Cancer UK and their new campaign, #WhatItTakes, which sheds light on the realities of blood cancer and the impact it has on those affected Join us in supporting @bloodcanceruk.bsky.social

In the latest edition of PULSE: Empowering the future of UK #biotech, we are excited to shine a spotlight on two innovative spinouts – MarraBio, and ConsoneAI Ltd, both of which have successfully secured funding to advance their groundbreaking research. ➡️ shorturl.at/co3ym

In their latest blog, Isabel Vincent, Market Development Manager at Firefinch Software, shares how they’re helping #LifeScience companies bring new products to market, harnessing #AI, and exploring cutting-edge imaging #Technologies. ➡️ shorturl.at/glvxE

🔬 Our Oligos explainer: A new frontier in precision medicine, explores the rise of #Oligonucleotides, an emerging class of complex medicines transforming #DiseaseTreatment ➡️ oligosexplainer.org The report highlights the potential of this breakthrough and why the sector must embrace its benefits. 🤝

We’re thrilled to announce the return of #TechBioUK on 16 October 2025 ➡️ shorturl.at/7tB1H Joining us on stage will be Chris Gibson, CEO of @recursionpharma.bsky.social, sharing insights at the cutting edge of techbio innovation. Don't miss out, buy your ticket now 🎟️👉 shorturl.at/7tB1H #KingsCross

In the third instalment of our updates on new Government policy, Lewis Miles and Maddie Cass take a deep dive into the #IndustrialStrategy and the Digital and Technologies Sector Plan, breaking down the implications for engineering biology and the wider #LifeSciences sector. ➡️ shorturl.at/xcwhH

Apply for the second cohort of the Science and Technology Venture Capital Fellowship, delivered by Imperial Business School & @raeng.org.uk.➡️ shorturl.at/wQ5h4 From November 2025 to September 2026, fellows will gain professional education, leadership development and unique networking opportunities.

#DeepBiotech holds the key to solving many of humanity’s most pressing challenges, driven by the climate crisis ➡️ shorturl.at/9LIil Linda Bedenik shares fresh analysis on the UK’s investment landscape, drawn from the updated edition of Deep Biotech: Disruptive Innovation for Global Sustainability.

Join a UK Government-backed Trade Mission to #Japan this October (3–11 Oct 2025) and tap into one of the world’s fastest-growing #bioeconomy markets. ➡️ shorturl.at/yqXPP

This quarter saw a surge in policy activity for UK #LifeSciences, as detailed in our Influencing and shaping our sector: April–June report. ➡️ shorturl.at/6oh9y We’ve worked to ensure the sector’s voice is reflected in Government decisions. Read the full report in the link above ⤴️

Just two days to go until the most anticipated gathering of the year! ➡️ shorturl.at/ORcS0 Don’t miss your chance to connect, celebrate, and enjoy the summer with the UK biotech community. Buy your 🎟️ ticket now! #BIASummerParty

Another BIA member making waves in the #LifeSciences sector! Huge congratulations to Portal Biotech on their $35M Series A raise 👏 ➡️ shorturl.at/FtdYm Portal Biotech is working to achieve full-length single-molecule protein sequencing, a breakthrough with the potential to transform drug discovery

Delighted to feature in the @bia-uk.bsky.social report on functional genomics as an example of its transformative power in UK healthcare. Proud to work at the intersection of AI and genomics - understanding complex biology to predict & prevent chronic diseases. 🔗 bioindustry.org/resource-rep...

There’s still time to grab your ticket and join us for the most anticipated event of the year… the #BIASummerParty! ➡️ shorturl.at/jOD2R Join 400+ of the sector’s finest for an unforgettable evening of cocktails, canapés, and high-level networking in the heart of #London.

🎥 Watch the full video to hear more on why representation matters and how we can empower more women to lead in 🧬 #LifeSciences. Discover more insights in our #WomeninBiotech Leadership: Representation at the C-Suite report. ➡️ bit.ly/4jgcBM7

BIA member Baringa is inviting you to take part in a short 5-minute survey to explore how Quality operates within your organisation and where your future priorities lie. ➡️ shorturl.at/FfNrf Deadline: 30 𝐉𝐮𝐧𝐞

The UK Government’s newly published Industrial Strategy puts #LifeSciences at the heart of its economic vision, highlighting the sector’s critical role in driving innovation, investment, and improved health outcomes. ➡️ shorturl.at/3RtJb Here's what Steve Bates OBE had to say ⤴️

Join our award-winning trade association! Currently recruiting for a Membership and Business Development Executive to join our Membership Team ➡️ shorturl.at/oAKC7 In this role, you'll: ✅ Lead and support new member acquisition efforts ✅ Plan and execute business development campaigns #ApplyNow

We sat down Natasha Grey, Associate & Life Sciences Advisory Service Lead, to find out how Warn is helping #Biotech companies unlock their full potential - and why they’re proud to call Victoria House in London’s Knowledge Quarter their new home ➡️ shorturl.at/fMvkp

🔬 #FunctionalGenomics is reshaping how we understand disease, design therapies, and improve patient outcomes.➡️ shorturl.at/hAOw1 Organisations like Johnson & Johnson are helping lead the charge, combining large-scale UK datasets (like UK Biobank and Our Future Health UK)

We are excited to launch our Functional genomics explainer: a Strategic opportunity for the UK 🧬➡️ shorturl.at/6YWlf #FunctionalGenomics represents the next frontier in #LifeSciences, moving beyond sequencing to truly understand how our #Genome functions and how genetic variation impacts #Health.

Dr Danuta Jeziorska, Co-Founder & CEO of Nucleome Therapeutics, shares insights for our upcoming report on #FunctionalGenomics. #ComingSoon

Richard Turner, newly appointed Vice Chair of FTAC and Senior Managing Director at @FTIConsulting, explores how the UK’s overhauled R&D tax framework strengthens its position as a destination of choice for drug development. ➡️ shorturl.at/CfKyR

This week was a big one for us as our policy team was in #Westminster alongside 50 senior figures from the UK #LifeSciences community, urging bold #Government action to deliver much-needed growth for the #UKEconomy ➡️ shorturl.at/367is

Join us on 19 June (4–8pm) @osborneclarkeuk.bsky.social for the first #DeepBiotech Community Connects, an exclusive BIA forum bringing together pioneers at the cutting edge of #EngineeringBiology ➡️ shorturl.at/s2G4Z 𝐓𝐡𝐢𝐬 𝐞𝐯𝐞𝐧𝐭 𝐢𝐬 𝐟𝐫𝐞𝐞 𝐟𝐨𝐫 𝐦𝐞𝐦𝐛𝐞𝐫𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐈𝐀 𝐃𝐞𝐞𝐩 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲.